Track Adamax in Peptimes™
Adamax is a product name, not a registered substance. New Zealand's medicines regulator, Medsafe, names it with Semax as an analogue of the hormone ACTH; no published source confirms its exact structure. (Source: Medsafe (New Zealand).)
Is Adamax FDA-approved?
No. Adamax isn't FDA-approved, and Drugs@FDA lists no application with it as an active ingredient.
Adamax
- Status label in the Peptimes Library
- Not FDA-Approved
- Routes in Peptimes
- SubcutaneousIntramuscularOralSublingualNasalTopicalOther
- Updated
- 1 Nov 2026
US regulatory status
How to track it in Peptimes
Add Adamax in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”.
- Routes: the app lets you record whichever route you used; none is established. Its routes are subcutaneous, intramuscular, oral, sublingual, nasal, topical and Other.
- Logging: the amount you took, the route and how you feel.
- Injection sites: subcutaneous and intramuscular doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next. Other routes skip this step.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell Adamax or any other compound.
More sources
- Medsafe (New Zealand’s medicines regulator), Classification of Unscheduled Peptides, June 2025, checked 1 Nov 2026: names Adamax and Semax as analogues of adrenocorticotropic hormone (ACTH).
- FDA, Drugs@FDA, checked 1 Nov 2026: no application lists Adamax as an active ingredient.